3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Arthritis, Rheumatoid
7
Melanoma
4
Colitis
3
Carcinoma, Non-Small-Cell Lung
3
Urogenital Neoplasms
2
Lung Neoplasms
2
Inflammatory Bowel Diseases
2
Inflammation
2
Fatigue
2
Depressive Disorder, Major
2
Depression
2
Colitis, Ulcerative
2
Vasculitis
1
Takayasu Arteritis
1
Syndrome
1
Stroke
1
Stevens-Johnson Syndrome
1
Spondylitis, Ankylosing
1
Skin Neoplasms
1
Psoriasis
1
Precancerous Conditions
1
Pemphigoid, Benign Mucous Membrane
1
Infections
1
Hypertension
1
Hepatitis C
1
Hematologic Neoplasms
1
Graft vs Host Disease
1
Drug-Related Side Effects and Adverse Reactions
1
Depressive Disorder, Treatment-Resistant
1
Cytokine Release Syndrome
1
Interventions
Saline Solution
1
Infliximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Depressive Disorder, Treatment-Resistant
×
Infliximab
×
Clear all
NCT00463580
2025-07-08
Infliximab
Emory University
Phase 4
Completed
60 enrolled
15 charts